| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.21B | +26.7% |
| Cost of Revenue | $2.35B | +16.4% |
| Gross Profit | $1.86B | +42.8% |
| R&D Expense | $191.4M | +25.7% |
| SG&A Expense | $188.3M | -4.7% |
| Operating Income | $1.39B | +62.7% |
| Pre-tax Income | $1.41B | +57.8% |
| Income Tax | $114.3M | +88.9% |
| Net Income | $1.29B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.62B | -16.7% |
| Accounts Receivable | $1.26B | +90.8% |
| Inventory | $1.08B | +32.3% |
| Current Assets | $5.09B | +9.8% |
| Total Assets | $12.12B | +17.0% |
| Current Liabilities | $2.08B | +59.0% |
| Long-term Debt | $373.4M | -19.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.22B | +102.2% |
| Capital Expenditures | $1.53B | +10.0% |
| Investing Cash Flow | -$1.56B | -230.7% |
| Financing Cash Flow | $24.8M | -92.6% |
| Free Cash Flow | -$308.1M | +60.7% |
| +55.5% |
| EPS (Basic) | $12.07 | +55.1% |
| EPS (Diluted) | $12.02 | +55.3% |
| Total Liabilities |
| $4.15B |
| +12.8% |
| Stockholders' Equity | $7.98B | +19.3% |